|
ZNF519 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.88604728793507E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.1833978241782E-11 |
| Normal-vs-Stage2 |
1.63900004679363E-11 |
| Normal-vs-Stage3 |
5.62716540031261E-12 |
| Normal-vs-Stage4 |
3.80709996861128E-09 |
| Stage1-vs-Stage2 |
4.324400E-01 |
| Stage1-vs-Stage3 |
5.808800E-01 |
| Stage1-vs-Stage4 |
8.415600E-01 |
| Stage2-vs-Stage3 |
7.260600E-01 |
| Stage2-vs-Stage4 |
7.267800E-01 |
| Stage3-vs-Stage4 |
9.133400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.53190826479977E-12 |
| Normal-vs-AfricanAmerican |
9.92250000053652E-07 |
| Normal-vs-Asian |
1.51429979666773E-10 |
| Caucasian-vs-AfricanAmerican |
9.592600E-01 |
| Caucasian-vs-Asian |
7.083600E-01 |
| AfricanAmerican-vs-Asian |
8.415200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.18567436056128E-13 |
| Normal-vs-Female |
2.69384514695048E-12 |
| Male-vs-Female |
3.015800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.05689901275241E-11 |
| Normal-vs-Age(41-60Yrs) |
4.63895588609375E-12 |
| Normal-vs-Age(61-80Yrs) |
4.39848157895995E-12 |
| Normal-vs-Age(81-100Yrs) |
1.9059000000432E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.265800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.277400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.001800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.017400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.230400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.068800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.010000E-01 |
| Classical-VS-Follicular |
7.298200E-01 |
| Classical-VS-Other |
8.004800E-01 |
| Classical-VS-Normal |
4.58909577005784E-11 |
| Tall-VS-Follicular |
1.220840E-01 |
| Tall-VS-Other |
6.191800E-01 |
| Tall-VS-Normal |
7.43038963690879E-12 |
| Follicular-VS-Other |
7.534000E-01 |
| Follicular-VS-Normal |
8.96639984482306E-10 |
| Other-VS-Normal |
3.89310000000753E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.20585829788934E-12 |
| Normal-vs-N1 |
7.15389969485614E-10 |
| N0-vs-N1 |
9.091600E-01 |
|
|
